Seres Therapeutics Inc (NASDAQ:MCRB)

BATS BZX Real-Time Price
As of 3:39pm ET
 -0.10 / -1.76%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 7 analysts offering 12-month price forecasts for Seres Therapeutics Inc have a median target of 12.00, with a high estimate of 25.00 and a low estimate of 4.00. The median estimate represents a +114.67% increase from the last price of 5.59.

Analyst Recommendations

The current consensus among 8 polled investment analysts is to Buy stock in Seres Therapeutics Inc. This rating has held steady since March, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Nov 09

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 33.04%
Growthannually -200.87%


Growthquarterly 218.12%
Growthannually -92.81%
Key to the earnings and sales forecast charts.